Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
However, Medicare covers Ozempic and Mounjaro for type 2 diabetes, and Zepbound may be covered for obstructive sleep apnea (FDA-approved December 2024)
with a stub of Hippocrates
Cost-effectiveness analysis A 2025 cost-effectiveness study published in PubMed found that tirzepatide was dominant over liraglutide from a UK healthcare perspective, meaning it produced both better outcomes and lower costs
It pairs them with real medical care, 1:1 coaching, and a peer-support app built to help you actually stick with it
US$ 20.29
US$ 25.56
US$ 20.90
US$ 27.23
